Announcements Trials

Browse Landscape

Phase

Phase 2 34 Phase 1 20 Phase NA 18 Phase 1/2 13 Phase 3 9 Phase EARLY_PHASE1 4 Phase 4 2 Phase 2/3 1

Status

Recruiting 50 Active not recruiting 19 Not yet recruiting 11 Completed 5 Suspended 3 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Terminated × 30 days × Clear all

NCT06295809 2026-05-08

INTerpath-007

Merck Sharp & Dohme LLC

Phase 2/3 Terminated

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡